Suppr超能文献

膳食胆固醇和脂肪酸对血浆低密度脂蛋白胆固醇水平的调节作用。

Regulation of plasma LDL-cholesterol levels by dietary cholesterol and fatty acids.

作者信息

Spady D K, Woollett L A, Dietschy J M

机构信息

Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235.

出版信息

Annu Rev Nutr. 1993;13:355-81. doi: 10.1146/annurev.nu.13.070193.002035.

Abstract

Extensive data obtained in both experimental animals and humans demonstrate that steady-state plasma LDL-C concentrations are determined largely by the rate of LDL-C formation, Jt, and the level of LDL-R activity, Jm, located primarily in the liver. An increase in net cholesterol delivery to the liver suppresses Jm, slightly elevates Jt, and modestly raises the LDL-C level. Feeding lipids such as the 12:0, 14:0, and 16:0 saturated fatty acids further suppresses Jm, increases Jt, and markedly elevates the plasma LDL-C concentration. Feeding triacylglycerols containing the 18:1(c9) fatty acid restores hepatic receptor activity, decreases Jt, and modestly reduces the concentration of LDL-C in the plasma. The 18:2(c9, c12) compound has similar effects, although it is quantitatively less active than the monounsaturated fatty acid in restoring Jm. In contrast to these fatty acids that actively raise or lower hepatic receptor activity, a large group of compounds including the 4:0, 6:0, 8:0, 10:0, 18:0, and 18:1(t9) fatty acids have no demonstrable effect on any parameter of LDL-C metabolism. These fatty acids, therefore, can be added to animal and human diets with relative impunity. They will alter plasma LDL-C levels only to the extent that they replace the active saturated fatty acids (in which case they lower the LDL-C concentration) or unsaturated compounds (in which case they raise the plasma cholesterol level). All of these effects of cholesterol and the various fatty acids can be explained by the effects of these lipids in altering the size of the regulatory pool of cholesterol in the hepatocyte. However, many aspects of the cellular and molecular biology of these regulatory processes require additional investigation. In particular, new studies should focus on how the genetic background of an individual animal or human alters the quantitative response of its plasma LDL-C concentration to the dietary challenge of each of these types of lipids.

摘要

在实验动物和人类中获得的大量数据表明,稳态血浆低密度脂蛋白胆固醇(LDL-C)浓度主要由LDL-C的生成速率Jt和主要位于肝脏的低密度脂蛋白受体(LDL-R)活性水平Jm决定。肝脏净胆固醇输送量增加会抑制Jm,轻微提高Jt,并适度升高LDL-C水平。喂食如12:0、14:0和16:0饱和脂肪酸等脂质会进一步抑制Jm,增加Jt,并显著提高血浆LDL-C浓度。喂食含有18:1(c9)脂肪酸的三酰甘油可恢复肝脏受体活性,降低Jt,并适度降低血浆中LDL-C的浓度。18:2(c9, c12)化合物有类似作用,尽管在恢复Jm方面其活性在数量上低于单不饱和脂肪酸。与这些能积极提高或降低肝脏受体活性的脂肪酸不同,一大类化合物,包括4:0、6:0、8:0、10:0、18:0和18:1(t9)脂肪酸,对LDL-C代谢的任何参数都没有明显影响。因此,这些脂肪酸可以相对安全地添加到动物和人类饮食中。它们只会在取代活性饱和脂肪酸(这种情况下会降低LDL-C浓度)或不饱和化合物(这种情况下会提高血浆胆固醇水平)的程度上改变血浆LDL-C水平。胆固醇和各种脂肪酸的所有这些作用都可以通过这些脂质改变肝细胞中胆固醇调节池大小的作用来解释。然而,这些调节过程的细胞和分子生物学的许多方面需要进一步研究。特别是,新的研究应关注个体动物或人类的遗传背景如何改变其血浆LDL-C浓度对每种此类脂质饮食挑战的定量反应。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验